Search research articles
Contact Us
Filters
Showing results (21-30 of 45) with videos related to
Page
of 5
Sort By:
Journal of the American Academy of Dermatology
|
August 1, 2020
Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign
Carlos Gustavo Wambier, Sergio Vaño-Galván, John McCoy, et al.
Journal of Cosmetic Dermatology
|
September 23, 2020
Novel cannabidiol sunscreen protects keratinocytes and melanocytes against ultraviolet B radiation
Pranjal Gohad, John McCoy, Carlos Wambier, et al.
Dermatologic Therapy
|
December 2, 2017
Styling without shedding: Novel topical formula reduces hair shedding by contracting the arrector pili muscle
John McCoy, Andy Goren, Maja Kovacevic, et al.
Acta Dermatovenerologica Alpina, Pannonica, Et Adriatica
|
December 20, 2019
Non-ablative radio frequency for the treatment of androgenetic alopecia
Yimei Tan, Liu Wei, Yiyi Zhang, et al.
Dermatologic Therapy
|
October 9, 2018
Characterization of follicular minoxidil sulfotransferase activity in a cohort of pattern hair loss patients from the Indian Subcontinent
Jill Chitalia, Rachita Dhurat, Andy Goren, et al.
Dermatologic Therapy
|
August 13, 2014
Clinical utility and validity of minoxidil response testing in androgenetic alopecia
Andy Goren, Jerry Shapiro, Janet Roberts, et al.
Journal of Cosmetic Dermatology
|
August 27, 2020
Novel "After Minoxidil" spray improves topical minoxidil compliance and hair style manageability
Maja Kovacevic, John McCoy, Jerry Shapiro, et al.
Dermatologic Therapy
|
April 3, 2020
What does androgenetic alopecia have to do with COVID-19? An insight into a potential new therapy
Andy Goren, John McCoy, Carlos G Wambier, et al.
Journal of Cosmetic Dermatology
|
June 16, 2021
SULT1A1 (Minoxidil Sulfotransferase) enzyme booster significantly improves response to topical minoxidil for hair regrowth
Rachita Dhurat, Sanober Daruwalla, Suraj Pai, et al.
Drug Development Research
|
May 16, 2020
Androgen sensitivity gateway to COVID-19 disease severity
Carlos Gustavo Wambier, Andy Goren, Sergio Vaño-Galván, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 45) with videos related to
Sort By:
Page
of 5
Journal of the American Academy of Dermatology
|
August 1, 2020
Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign
Carlos Gustavo Wambier, Sergio Vaño-Galván, John McCoy, et al.
Journal of Cosmetic Dermatology
|
September 23, 2020
Novel cannabidiol sunscreen protects keratinocytes and melanocytes against ultraviolet B radiation
Pranjal Gohad, John McCoy, Carlos Wambier, et al.
Dermatologic Therapy
|
December 2, 2017
Styling without shedding: Novel topical formula reduces hair shedding by contracting the arrector pili muscle
John McCoy, Andy Goren, Maja Kovacevic, et al.
Acta Dermatovenerologica Alpina, Pannonica, Et Adriatica
|
December 20, 2019
Non-ablative radio frequency for the treatment of androgenetic alopecia
Yimei Tan, Liu Wei, Yiyi Zhang, et al.
Dermatologic Therapy
|
October 9, 2018
Characterization of follicular minoxidil sulfotransferase activity in a cohort of pattern hair loss patients from the Indian Subcontinent
Jill Chitalia, Rachita Dhurat, Andy Goren, et al.
Dermatologic Therapy
|
August 13, 2014
Clinical utility and validity of minoxidil response testing in androgenetic alopecia
Andy Goren, Jerry Shapiro, Janet Roberts, et al.
Journal of Cosmetic Dermatology
|
August 27, 2020
Novel "After Minoxidil" spray improves topical minoxidil compliance and hair style manageability
Maja Kovacevic, John McCoy, Jerry Shapiro, et al.
Dermatologic Therapy
|
April 3, 2020
What does androgenetic alopecia have to do with COVID-19? An insight into a potential new therapy
Andy Goren, John McCoy, Carlos G Wambier, et al.
Journal of Cosmetic Dermatology
|
June 16, 2021
SULT1A1 (Minoxidil Sulfotransferase) enzyme booster significantly improves response to topical minoxidil for hair regrowth
Rachita Dhurat, Sanober Daruwalla, Suraj Pai, et al.
Drug Development Research
|
May 16, 2020
Androgen sensitivity gateway to COVID-19 disease severity
Carlos Gustavo Wambier, Andy Goren, Sergio Vaño-Galván, et al.
Page
of 5